Search

everythinglearnresearchcommunity

for

Search:↓

During the COVID-19 pandemic, dermatology visits decreased, especially among older patients, patients of color, men, and those with chronic conditions.

Elderly patients frequently suffer from skin conditions, especially inflammatory ones, highlighting the need for better healthcare.

Alopecia causes significant emotional distress and psychological issues, requiring combined skin and mental health treatment.

Some skin medications can harm male fertility, but they don't seem to cause birth defects from father's exposure.

Mood stabilizers for bipolar disorder can cause skin issues, but severe reactions are rare.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

High androgen levels cause skin issues in PCOS, affecting quality of life.

Topical L-thyroxine may help with wound healing and hair growth but should be used short-term due to potential risks.

The conclusion is that recognizing the difference between gender identity and biological sex is crucial in dermatology to improve patient care and research accuracy.

The LGBT-focused curriculum improved dermatology residents' confidence in treating LGBT patients.

Targeting mitochondria can improve skin health and slow aging.

Fat-derived stem cells show promise for skin repair and reducing aging signs but need more research for consistent results.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Taking biotin supplements can be risky and often lacks evidence of effectiveness for skin, hair, and nail issues.

The COVID-19 pandemic increased some stress-related skin diseases but didn't affect others.

Skin issues from chronic graft-versus-host disease greatly affect daily life, needing teamwork between blood and skin doctors.

Lifestyle changes during the early COVID-19 outbreak led to more cases of acne and other skin conditions, but fewer cases of rosacea and skin infections.

Lithium therapy may cause skin problems like hidradenitis suppurativa and other side effects, which can improve after stopping the medication.

COVID-19 can cause long-term skin problems and has changed how skin doctors work.

COVID-19 patients with skin signs often stayed in the hospital for less time than those without skin signs.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Childhood cancer diagnosis leads to long-term physical and emotional health issues in parents.

Permanent eyebrow correction can improve quality of life for those with eyebrow loss.

Epigenetic changes in skin cells contribute to aging, but targeting these changes may offer new antiaging treatments.

The COVID-19 quarantine in Turkey disrupted dermatological care, increased stress-related skin issues, and showed the need for psychological support and teledermatology.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Switching immunosuppressants can improve hair regrowth and well-being in transplant patients experiencing hair loss.

Switching immunosuppressive drugs can improve hair regrowth and well-being in transplant patients with hair loss.

Hair loss from immunosuppressive drugs in transplant patients can affect well-being and treatment adherence, so personalized management is important.

Understanding both skin and mental health aspects of alopecia areata is crucial for better patient care.